1 / 20

Biological and Radiological Regulatory Concerns for Research Administrators

Biological and Radiological Regulatory Concerns for Research Administrators. Megan G. Marks, Ph.D. Biological and Radiological Safety Manager Carnegie Mellon University August 2003. Introduction. Biological and Radiological Agents are valuable tools in research.

hope-walker
Download Presentation

Biological and Radiological Regulatory Concerns for Research Administrators

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Biological and Radiological Regulatory Concerns for Research Administrators Megan G. Marks, Ph.D. Biological and Radiological Safety Manager Carnegie Mellon University August 2003

  2. Introduction • Biological and Radiological Agents are valuable tools in research. • Both types of agents are used in a variety of disciplines, ranging from the biological sciences to physics.

  3. Purpose of Training • Provide the necessary knowledge to assist the university and its researchers in maintaining local, state, and federal compliance regarding the use of biological and radiological agents

  4. Biological Regulatory ConcernsDefinitions • Biological agents • means any microorganism (including, but not limited to, bacteria, viruses, fungi, rickettsiae, or protozoa), or infectious substance, or any naturally occurring, bioengineered, or synthesized component of any such microorganism or infectious substance, capable of causing death, disease, or other biological malfunction in a human, an animal, a plant, or another living organism; deterioration of food, water, equipment, supplies, or material of any kind; or deleterious alteration of the environment In short: an infectious substance that has the potential to cause disease in other living organisms

  5. Biological Regulatory ConcernsDefinitions • DNA • Deoxyribonucleic acid (DNA) • Building block of life • Molecule encodes different characteristics in all living things • All living things have different DNA molecules • Identical twin exception • Recombinant DNA (rDNA) • DNA manipulated outside the body but is not injected into a person

  6. Biological Regulatory ConcernsDefinitions • Select Agent • means a biological agent included in the Code of Federal Regulations Title 7 Part 331.3, Title 9 Part 121.3, and Title 42 Part 73.4 • Refer to listing provided at the end of the presentation • Bloodborne Pathogen • Bloodborne pathogens means pathogenic microorganisms that are present in human blood and can cause disease in humans. These pathogens include, but are not limited to, hepatitis B virus (HBV) and human immunodeficiency virus (HIV).

  7. Biological Regulatory ConcernsDefinitions • Controlled Substances • Drugs and certain other chemicals, both narcotic and non-narcotic, which come under the jurisdiction of federal and state laws regulating their manufacture, sale, distribution, use and disposal.

  8. Biological Regulatory ConcernsRegulatory Agencies • Department of Health and Human Services (DHHS) • Center for Disease Control • United States Department of Agriculture • Department of Transportation • Drug Enforcement Agency (DEA) • National Institute of Health • NIH Guidelines for Research Involving rDNA molecules

  9. Biological Regulatory ConcernsUniversity Committee • Institutional Biological Safety Committee (IBC) • rDNA • *Biological agents, select agents, and controlled substances • Presently, there is not a review established for the agents and • substances that are not rDNA. It is the intent of the Biosafety • Program to initiate this process.

  10. Biological Regulatory ConcernsPrincipal Investigator Responsibility • PIs must submit an authorization application to the Office of Sponsored Research and receive approval by the Institutional Biosafety Committee (IBC) prior to the commencement of any research utilizing recombinant DNA (rDNA). • PIs must contact the Biosafety Office prior to purchasing any select agent or importing any biological agent or environmental sample. Any effort to purchase or import such agents must be coordinated through the Biosafety Office • All select agents must be shipped to the Biosafety Office

  11. Biological Regulatory ConcernsPrincipal Investigator Responsibility The CM *Safety Plan for the Use of Biological Agents contains information that all users of biological agents at CM should know To Be Completed • Presently, this is being authored. Upon final review of the IBC it will be • Distributed and posted on the EHS website.

  12. Biological Regulatory ConcernsUsers of Biological Agents Responsibility • Follow the rules and regulations established by CM and all applicable laws • Escort untrained personnel, contractors, and visitors in areas that biological agents are stored and/or used.

  13. Biological Regulatory ConcernsFurther Information…………. • Questions can be addressed to the Biosafety Office • 268-3221 • mmarks@andrew.cmu.edu • Web site *http://www.cmu.edu/ehs/biosafety.htm • Location 313 Mellon Institute • Presently, this web-site is under construction.

  14. Radiological Regulatory ConcernsDefinitions • Sources of Radiation • Radionuclides, radioactivated materials (by irradiation or by exchange processes), "Radiation Producing Machines or Devices," "Generally Licensed Devices," and those quantities of radioisotopes defined by regulation to be exempt quantities. • Radiation Producing Devices • A machine or device capable of generating radiation, such as X-ray producing machines, particle accelerators, high voltage power supplies, electron microscopes, high voltage rectifiers, high voltage projection equipment, and other types of high voltage machines.

  15. Radiological Regulatory ConcernsRegulatory Agencies • Nuclear Regulatory Commission • Pennsylvania Department of Environmental Protection • Department of Transportation • Environmental Protection Agency

  16. Radiological Regulatory ConcernsUniversity Committee • Radiation Safety Committee (RSC) • Radioactive material • Radiation Producing Devices

  17. Radiological Regulatory ConcernsPrincipal Investigator Responsibility • PIs must submit an authorization application to the Radiation Safety (RS) Office and receive approval by the Radiation Safety Committee (RSC) prior to the commencement of any research utilizing radionuclides or radiation producing equipment. • All radioactive material must be ordered through the RS Office • All radioactive material must be shipped to the RS Office, 313 Mellon Institute, 4400 Fifth Avenue, Pittsburgh, PA 15213

  18. Radiological Regulatory ConcernsPrincipal Investigator Responsibility The CM Safety Plan for the Use of Radioactive Materials and Radiation Producing Devices contains information that all users of radiation sources at CM should know

  19. Radiological Regulatory ConcernsRadiation Worker Responsibility • Follow the rules and attempt to maintain ALARA at all times. • Escort untrained personnel or contractors. • Survey hands and feet prior to exiting RAM area that unsealed sources are used or stored.

  20. Radiological Regulatory ConcernsFurther Information…………. • Questions can be addressed to the Radiation Safety Office • 268-3221 • mmarks@andrew.cmu.edu • Web site http://www.cmu.edu/ehs/radiation.htm • Location 313 Mellon Institute

More Related